1709MO Multi-center NCI-sponsored phase I study of triapine in combination with 177Lu-dotatate in patients with well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
A. Chauhan, C.A. Kunos, B. Konda, H. Weiss, H.P. Soares, D. Li, T.R. Halfdanarson, M.F. Mulcahy, J. Beumer, P. Wu, …
1709MO Multi-center NCI-sponsored phase I study of triapine in combination with 177Lu-dotatate in patients with well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
Creators
A. Chauhan
C.A. Kunos
B. Konda
H. Weiss
H.P. Soares
D. Li
T.R. Halfdanarson
M.F. Mulcahy
J. Beumer
P. Wu
B. Das
W. Carson
L. Rubinstein
S. Gore
L. Pelosof
P. Ivy
E.C. Kohn
L. Anthony
S.M. Arnold
Publication Details
Annals of oncology, Vol.36, p.S1008
Publisher
ELSEVIER; AMSTERDAM
Number of pages
1
Grant note
National Cancer Institute (CTEP)
National Cancer Institute (CTEP).
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology; UMMG Dept of Radiation Oncology